Close

content

Vetter Further Expands its Development Service with New Site in Austria

With biopharmaceutical development heavily focused on specialized therapeutics, drug sponsors are increasingly turning to expert outsourcing partners to meet growing demand for complex fill...

Coronavirus Vaccine: Cipla’s remdesivir Cipremi launched in India, lowest priced drug for COVID-19

Pharma major Cipla said it has launched its generic version of antiviral drug remdesivir at a price which is among the lowest globally and...

1 of every 20 air cargo, carried throughout the world, rises by Turkish Cargo

According to the data announced for May by the WACD (World Air Cargo Data), the international air cargo information provider, Turkish Cargo, the global...

Amcor Research Provides Insights into Consumer Attitudes Towards Responsible Packaging

Global packaging leader Amcor published results from its latest research into consumer perceptions of sustainability and packaging. The proprietary insights give Amcor and its...

CURE Pharmaceutical Receives NSF cGMP Certification for Dietary Supplements

CURE Pharmaceutical, an innovative drug delivery and development company, announced that its 25,000 square foot manufacturing facility has earned NSF International, cGMP certification for...

Numab Therapeutics and Boehringer Ingelheim Enter into Collaboration to Develop Multi-specific Antibody Therapeutics for Cancer and Retinal Diseases

Boehringer Ingelheim and Numab Therapeutics announced that they have entered into a research collaboration and worldwide licensing agreement. It will start with two projects...

AstraZeneca-Merck’s Lynparza wins EU approval for pancreatic cancer

AstraZeneca and MSD Inc., Kenilworth, N.J., US announced that Lynparza (olaparib) has been approved in the EU for patients with germline BRCA-mutated (gBRCAm) metastatic...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read